维普中文期刊产品整合服务
7篇 您的检索式:作者名="Niu RC"
    题名 作者 年代 出处 被引量
1Pulmonary infection control window in treatment of severe respiratory failure of chronic obstructive pulmonary diseases: a prospective, randomized controlled, multi-centred study显示文摘Background Early withdraw from invasive mechanical ventilation (MV) followed by noninvasive MV is a new strategy for changing modes of treatment. This study was conducted to estimate the feasibility and the efficacy of early extubation and sequential noninvasive MV commenced at beginning of pulmonary infection control window in patients with exacerbated hypercapnic respiratory failure caused by chronic obstructive pulmonary diseases (COPD). Methods A prospective, randomized controlled study was conducted in eleven teaching hospitals' respiratory or medical intensive care units in China. Ninety intubated COPD patients with severe hypercapnic respiratory failure triggered by pulmonary infection (pneumonia or purulent bronchitis) were involved in the study. When the pulmonary infection had been controlled by antibiotics and comprehensive therapy, the 'pulmonary infection control window (PIC window)' has been reached. Each case was randomly assigned to study group (extubation and noninvasive MV via facial mask immediately) or control group (invasive MV was received continuously after PIC window by using conventional weaning technique).Results Study group (n=47) and control group (n=43) had similar clinical characteristics initially and at the time of PIC window. Compared with control group, study group had shorter duration of invasive MV [(6.4±4.4) days vs (11.3±6.2) days, P=0.000], lower rate of ventilator associated pneumonia (VAP) (3/47 vs 12/43, P=0.014), fewer days in ICU [(12±8) days vs (16±11) days, P=0.047] and lower hospital mortality (1/47 vs 7/43, P=0.025).Conclusions In COPD patients requiring intubation and invasive MV for hypercapnic respiratory failure, which is exacerbated by pulmonary infection, early extubation followed by noninvasive MV initiated at the start of PIC window may decrease significantly the duration of invasive MV, the risk of VAP and hospital mortality.Wang, C Zhan, QY Cao, ZX Wei, LQ Cheng, ZZ Liu, S Zhang, JL Chen, RC Luo, Q Niu, SF Zhu, L Wu, DW Fang, BM Wu, TH Wang, CZ Liu, YN 2005Chinese Medical Journal2005,,19:6
2Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease:the role of TGF-beta/Smads signaling pathways显示文摘Luo BL Niu RC Feng JT 0,,:1
3Downregulation of secretory leukyte proteinase inhibitor in chronic obstructive lung disease:the role of TGF-beta/Smads signaling pathways显示文摘Luo BL Niu RC Feng JT 0,,:1
4Downregulation of secretory leukocyte proteinase inhibitor in chronic obstructive lung disease : the role of TGF-beta/Smads signaling pathways 显示文摘Luo BL Niu RC Feng JT 2008Arch Med Res2008,39,4:1
5Down-regulation of secretory leuko- cyte proteinaes inhibitor in chronic obstructive lung disease:the role of TGF-beta/Smads signaling pathways显示文摘Luo BL Niu RC Feng JT 2008Arch Med Res2008,39,4:1
6Downregulation of secretory leu- kocyte proteinase inhibitor in chronic obstructive lung disease : the role of TGF--beta/Smadssignaling pathways 显示文摘Luo BL Niu RC Fang JT 2008Arch Med Res2008,39,:1
7Downregulation of secreto- ry leukocyte proteinase inhibitor in chronic obstructive lung disease :the role of TGF-beta/Smads signaling pathways 显示文摘Luo BL Niu RC Feng JT 2008Arch Med Rest2008,39,4:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费